BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 11885937)

  • 1. Epstein-Barr virus.
    Rickinson A
    Virus Res; 2002 Jan; 82(1-2):109-13. PubMed ID: 11885937
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunologic tests: Epstein-Barr virus].
    Mizuno F
    Nihon Rinsho; 2005 Jul; 63 Suppl 7():300-3. PubMed ID: 16111256
    [No Abstract]   [Full Text] [Related]  

  • 3. B cells under influence: transformation of B cells by Epstein-Barr virus.
    Küppers R
    Nat Rev Immunol; 2003 Oct; 3(10):801-12. PubMed ID: 14523386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of the Epstein-Barr virus in human pathology].
    Rupniewska ZM
    Acta Haematol Pol; 1979; 10(3):183-91. PubMed ID: 228518
    [No Abstract]   [Full Text] [Related]  

  • 5. Epstein-barr-virus nuclear antigen.
    Vonka V; Hirsch I
    Prog Med Virol; 1982; 28():145-79. PubMed ID: 6283600
    [No Abstract]   [Full Text] [Related]  

  • 6. The promise of a prophylactic Epstein-Barr virus vaccine.
    Balfour HH; Schmeling DO; Grimm-Geris JM
    Pediatr Res; 2020 Jan; 87(2):345-352. PubMed ID: 31641280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The Epstein-Barr virus infects immunologic cells].
    Ernberg I; Britton S
    Lakartidningen; 1983 Feb; 80(8):689-92. PubMed ID: 6306366
    [No Abstract]   [Full Text] [Related]  

  • 8. The Effects of Epstein-Barr Virus Nuclear Antigen 2 (EBNA2) on B-Lymphocytic Activity.
    Qu M; Ding F; Di S; Zhang S; Yu X
    Clin Lab; 2018 Apr; 64(4):425-431. PubMed ID: 29739075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody titers against EBNA1 and EBNA2 in relation to Hodgkin lymphoma and history of infectious mononucleosis.
    Mueller NE; Lennette ET; Dupnik K; Birmann BM
    Int J Cancer; 2012 Jun; 130(12):2886-91. PubMed ID: 21805472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody patterns in different human sera against intracellular and membrane-antigen complexes associated with Epstein-Barr virus.
    Svedmyr A; Demissie A; Klein G; Clifford P
    J Natl Cancer Inst; 1970 Mar; 44(3):595-610. PubMed ID: 11515428
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of LMP1 in immune control of EBV infection.
    Pai S; Khanna R
    Semin Cancer Biol; 2001 Dec; 11(6):455-60. PubMed ID: 11669607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restricted low-level human antibody responses against Epstein-Barr virus (EBV)-encoded latent membrane protein 1 in a subgroup of patients with EBV-associated diseases.
    Meij P; Vervoort MB; Aarbiou J; van Dissel P; Brink A; Bloemena E; Meijer CJ; Middeldorp JM
    J Infect Dis; 1999 May; 179(5):1108-15. PubMed ID: 10191211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired Epstein-Barr Virus-Specific Neutralizing Antibody Response during Acute Infectious Mononucleosis Is Coincident with Global B-Cell Dysfunction.
    Panikkar A; Smith C; Hislop A; Tellam N; Dasari V; Hogquist KA; Wykes M; Moss DJ; Rickinson A; Balfour HH; Khanna R
    J Virol; 2015 Sep; 89(17):9137-41. PubMed ID: 26109734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccine Development for Epstein-Barr Virus.
    Cohen JI
    Adv Exp Med Biol; 2018; 1045():477-493. PubMed ID: 29896681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus-specific IgM in infectious mononucleosis, Burkitt lymphoma, nasopharyngeal carcinoma.
    Banatvala JE; Best JM; Waller DK
    Lancet; 1972 Jun; 1(7762):1205-8. PubMed ID: 4113190
    [No Abstract]   [Full Text] [Related]  

  • 16. [Immunology of Epstein-Barr virus in lymphoproliferative diseases].
    Bachmann AE; Giraudo Conesa LC; Braun M
    Medicina (B Aires); 1974 Mar; 34(2):157-66. PubMed ID: 4368156
    [No Abstract]   [Full Text] [Related]  

  • 17. Spectrum of Epstein-Barr virus-associated diseases.
    Kutok JL; Wang F
    Annu Rev Pathol; 2006; 1():375-404. PubMed ID: 18039120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus-related serology in Hodgkin's disease.
    Henle W; Henle G
    Natl Cancer Inst Monogr; 1973 May; 36():79-84. PubMed ID: 4355353
    [No Abstract]   [Full Text] [Related]  

  • 19. CD4+ T cell responses in the immune control against latent infection by Epstein-Barr virus.
    Paludan C; Münz C
    Curr Mol Med; 2003 Jun; 3(4):341-7. PubMed ID: 12776989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxic antibodies to cultured lymphoblasts unrelated to Epstein-Barr virus.
    Yang CS; Hewetson JF
    Int J Cancer; 1974 Oct; 14(4):530-8. PubMed ID: 4376526
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.